» Articles » PMID: 3929246

Secondary Structure of the Immunoglobulin J Chain

Overview
Specialty Science
Date 1985 Sep 1
PMID 3929246
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

J chain is a 137-residue polypeptide that is covalently linked to polymeric immunoglobulins and participates in their synthesis and transport to external secretions. To clarify these roles, the secondary structure of J chain was characterized by computer-assisted analyses of human and mouse sequences and by circular dichroism measurements of the isolated J chain. The secondary-structure profiles obtained were very similar to those of superoxide dismutase or immunoglobulin light chain variable domains, suggesting that the J chain folds into an eight-stranded antiparallel beta-barrel and should contain approximately 37% beta-sheet conformation, with the rest of the structure existing as reverse turns (random coil). The circular dichroism measurements indicated that the conformation of denatured, S-carboxymethylated or S-sulfonated J chain consists of 75% random coil and 25% beta-structure. Upon reformation of disulfide bonds the percentage of beta-structure in the air-oxidized J chain increased to 34%, a value that is in good agreement with the secondary-structure analysis. Two alternative models of J-chain structure, a two-domain model [Cann, G., Zaritsky, A. & Koshland, M.E. (1982) Proc. Natl. Acad. Sci. USA 79, 6656-6660] and a single-domain antiparallel beta-sheet bilayer model (proposed in this paper), are compared.

Citing Articles

Stability and heterogeneity in the antimicrobiota reactivity of human milk-derived immunoglobulin A.

Johnson-Hence C, Gopalakrishna K, Bodkin D, Coffey K, Burr A, Rahman S J Exp Med. 2023; 220(8).

PMID: 37462916 PMC: 10354535. DOI: 10.1084/jem.20220839.


Stability and heterogeneity in the anti-microbiota reactivity of human milk-derived Immunoglobulin A.

Johnson-Hence C, Gopalakrishna K, Bodkin D, Coffey K, Burr A, Rahman S bioRxiv. 2023; .

PMID: 36993366 PMC: 10055037. DOI: 10.1101/2023.03.16.532940.


Mucosal Immunity and the Gut-Microbiota-Brain-Axis in Neuroimmune Disease.

Sterling K, Dodd G, Alhamdi S, Asimenios P, Dagda R, De Meirleir K Int J Mol Sci. 2022; 23(21).

PMID: 36362150 PMC: 9655506. DOI: 10.3390/ijms232113328.


Structure, Function, and Therapeutic Use of IgM Antibodies.

Keyt B, Baliga R, Sinclair A, Carroll S, Peterson M Antibodies (Basel). 2020; 9(4).

PMID: 33066119 PMC: 7709107. DOI: 10.3390/antib9040053.


Not all therapeutic antibody isotypes are equal: the case of IgM IgG in Pertuzumab and Trastuzumab.

Samsudin F, Yeo J, Gan S, Bond P Chem Sci. 2020; 11(10):2843-2854.

PMID: 32206268 PMC: 7069520. DOI: 10.1039/c9sc04722k.


References
1.
Levitt M, Chothia C . Structural patterns in globular proteins. Nature. 1976; 261(5561):552-8. DOI: 10.1038/261552a0. View

2.
Richardson J, Richardson D, Thomas K, Silverton E, Davies D . Similarity of three-dimensional structure between the immunoglobulin domain and the copper, zinc superoxide dismutase subunit. J Mol Biol. 1976; 102(2):221-35. DOI: 10.1016/s0022-2836(76)80050-2. View

3.
Koshland M, Chapuis R, Recht B, Brown J . Selective proteolysis of the J chain component in human polymeric immunoglobulin. J Immunol. 1977; 118(3):775-81. View

4.
Mole J, BHOWN A, Bennett J . Primary structure of human J chain: alignment of peptides from chemical and enzymatic hydrolyses. Biochemistry. 1977; 16(16):3507-13. DOI: 10.1021/bi00635a002. View

5.
Early P, Rogers J, Davis M, Calame K, Bond M, Wall R . Two mRNAs can be produced from a single immunoglobulin mu gene by alternative RNA processing pathways. Cell. 1980; 20(2):313-9. DOI: 10.1016/0092-8674(80)90617-0. View